Products

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

See all 1 product →

About Fimo Health GmbH (Consortium Leader)

Fimo Health GmbH is a German healthcare AI company focused on improving the quality of life for individuals with chronic diseases, particularly those experiencing fatigue. The company develops digital health solutions, primarily a mobile app, that combines disease-specific knowledge with symptom tracking. This allows patients to better understand and proactively manage their symptoms, such as fatigue, which is a common and debilitating symptom in conditions like Multiple Sclerosis (MS), Long Covid, cancer, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), rheumatoid arthritis, and fibromyalgia.

The Fimo Health app utilizes data from various sources, including smartphone sensors and connected wearables, to measure vital parameters (e.g., pulse, HRV, sleep) and environmental factors (e.g., light, noise, weather) that can influence fatigue. Through the application of artificial intelligence and scientific tests, the app aims to provide personalized insights and interventions, such as behavioral and movement therapy, to help patients manage their fatigue and avoid exceeding their stress limits. The company also collaborates with healthcare providers, insurance companies, and pharmaceutical partners to integrate their solutions into broader healthcare strategies, aiming to improve patient outcomes and reduce healthcare costs.

Fimo Health is actively involved in research and development, including a clinical trial with MS patients and leading the FAITH project, which focuses on AI-based diagnostics and treatment of tumor-associated fatigue syndrome, funded by the state of North Rhine-Westphalia. Their app is CE-certified and has been recognized as the first certified medical device for the treatment of Long Covid. The company’s solutions are designed to empower patients to become active managers of their own health, providing data-driven recommendations and support.

Focus Areas

chronic fatigue multiple sclerosis long Covid ME/CFS cancer rheumatoid arthritis fibromyalgia digital therapeutics symptom management patient empowerment AI-based diagnostics

Business Intelligence

Key InvestorsLUMO Labs, Barmenia Next Strategies, NRW.Bank, Rockstart
PartnershipsUniversity of Cologne, University Hospital of Cologne, University of Bonn, University of Witten-Herdecke, Merck, Samsung, Garmin, Essen University Medical Center, Jülich Palliative Medicine Research Institute, Fraunhofer Institute for Microelectronics Circuits and systems (IMS), DAK-Gesundheit, SBK
Acquisitionsunknown
TechnologyCloud-native, AI-powered mobile application, utilizes smartphone and wearable sensor data (e.g., Garmin smartwatches)
FDA Clearancesunknown (CE-certified medical device for Long Covid) cleared products (estimated)

What Physicians Need to Know

Specialization in Chronic Conditions
Fimo Health GmbH specializes in supporting patients with chronic conditions such as chronic fatigue syndrome (ME/CFS), multiple sclerosis (MS), Long Covid, cancer, rheumatoid arthritis, fibromyalgia, Crohn's disease, and ulcerative colitis.
Digital Therapeutics & Symptom Management
They offer a digital solution, the Fimo Health app, which acts as an everyday companion for chronic illnesses. It combines learning content with structured symptom tracking to help patients proactively manage their illness and associated symptoms.
AI-based Diagnostics & Data Analysis
The Fimo Health app utilizes artificial intelligence and data from various devices (smartwatches for vital parameters like pulse, HRV, sleep; phone sensors for environmental parameters like light, noise, weather) along with questionnaires and cognitive tests. This data helps individuals understand their fatigue, avoid exceeding stress limits, and track the effectiveness of therapies and medications.
Patient Empowerment
A core focus is patient empowerment through quality-assured knowledge, methods of cognitive behavioral therapy, and elements of behavioral change. The app provides interactive content, exercises, tips, and tricks to help patients understand influencing factors, build new routines, and improve their quality of life.
Research & Development
Fimo Health is a spin-off of the University of Cologne and collaborates with other research partners like the University of Bonn and the University of Witten-Herdecke, as well as industry partners such as Merck and Samsung. They are actively conducting clinical trials, for instance, with MS patients, and developing an app for Long Covid diagnosis based on heart rate variability (HRV) and other data.
Physician Tip

Fimo Health provides physicians with objective data on fatigue and its influencing factors, which can lead to more individualized therapies and drug plans. The app's structured documentation of symptoms, behavioral data, and vital/environmental factors offers valuable insights into a patient's health history. This data can assist in medical history taking and in understanding patient adherence to medication. The company also aims to offer SDK/White Label solutions for pharmaceutical companies, CROs, and research institutes, facilitating data integration and research.

The Fimo Health app integrates with smartwatches (currently primarily Garmin devices, with plans for more providers) to collect vital parameters. They are also developing their solution to include an SDK/White Label component for integration into other existing apps or for use by pharmaceutical companies, CROs, and research institutes. Data security is a priority, with patient data stored on German servers in compliance with GDPR.

Products by Fimo Health GmbH (Consortium Leader)

1 product in the directory

FAITH project (Fatigue Therapy – AI-supported Diagnosis and Therapy of Tumour-associated Fatigue Syndrome)
Fimo Health GmbH (Consortium Leader)
Mental & Behavioral Health AI
The FAITH project is developing an AI-based solution for the diagnosis and therapy of tumor-associated fatigue syndrome in cancer patients. It uses wearable sensors, a smartphone app, and artificial intelligence to provide individualized therapy recommendations and monitor mental health.

What the Web Says

Fimo Health GmbH develops a CE-certified digital health application designed to support patients with chronic inflammatory and fatigue-related conditions, such as Long Covid, ME/CFS, Multiple Sclerosis, Fibromyalgia, and Rheumatoid Arthritis. The app offers symptom monitoring, educational modules, and evidence-based exercises. Early studies and user feedback suggest the app is usable, well-accepted, and may offer potential benefits in improving physical quality of life and self-management of conditions.

Overall: Positive

Strengths

  • Supports self-management of chronic inflammatory and fatigue-related conditions.
  • Offers interactive themed journeys, practical exercises, and a symptom diary.
  • Content is scientifically based and developed with leading university hospitals and researchers.
  • App is CE-certified as a medical product and GDPR compliant.
  • Potential for improved physical quality of life and reduced fatigue.
  • Ability to connect with smartwatches for enhanced tracking and doctor reports.

Limitations

  • Limited public reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit.
  • Apple App Store shows very few ratings and reviews for the app.
  • No readily available employer reviews were found on platforms like Glassdoor or Indeed specifically for Fimo Health GmbH.
  • The information about the company is primarily from their own descriptions and research studies they are involved in.

Based on reviews from: Apple App Store, Google Play Store, PubMed Central, University of Cologne - Department of Operations Management, APKPure

Last updated: 2026-09-12

Videos

News, demos, and interviews about Fimo Health GmbH (Consortium Leader).

Loading videos...

Videos load interactively. If none appear, search YouTube for Fimo Health GmbH (Consortium Leader) →

View all on YouTube

Frequently Asked Questions

Fimo Health's digital therapeutic primarily addresses chronic fatigue associated with conditions like Long COVID, ME/CFS, Multiple Sclerosis, cancer, rheumatoid arthritis, and fibromyalgia. For patients, it offers symptom tracking, personalized tips, and educational content to better understand and manage their condition. For physicians, the app provides structured documentation of patient-reported outcomes, symptoms, and wearable data, which can aid in medical history taking and therapy monitoring.
Fimo Health emphasizes GDPR compliance and stores patient data securely on German servers. Their app is a CE-certified medical device, and they are actively involved in research projects that include AI-supported diagnostics, with a focus on ethical data handling and regulatory adherence.
Fimo Health's app is often reimbursed by German health insurance companies, making it free for insured patients. They also explore B2B2C models with health insurers and offer solutions for pharmaceutical companies and research institutes, including SDK/White Label components for integration into other apps.
Fimo Health provides a ready-to-use infrastructure for quick implementation, with configurable options for study protocols and live dashboards for monitoring. They also offer structured data collection, evidence-based intervention modules, and support for integrating their solution into existing research projects and EDC systems.
Fimo Health is a spin-off of the University of Cologne and collaborates with other research partners like the University of Bonn and the University of Witten-Herdecke, as well as industry partners such as Merck and Samsung. They have secured funding from LUMO Labs, Barmenia Next Strategies, NRW.Bank, and Rockstart, indicating strong investor confidence and a strategic focus on market leadership and international expansion.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.